Related Experiment Videos
Olfactory ensheathing cells and spinal cord repair
1Institute for Cell and Molecular Therapies, Griffith University, Brisbane, Qld, Australia. A.Mackay-Sim@griffith.edu.au
The Keio Journal of Medicine
|April 16, 2005
Summary
Transplanting olfactory ensheathing cells from the nose promotes spinal cord repair and functional recovery in rats. Human trials are now underway for paraplegic patients.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Glial Cell Biology
Background:
- Olfactory ensheathing cells (OECs) are specialized glial cells supporting olfactory sensory neuron axon growth.
- Animal studies suggest OEC transplantation aids spinal cord injury (SCI) recovery by promoting axon regeneration and functional improvement.
- Current research primarily uses OECs from the olfactory bulb, posing challenges for human accessibility.
Purpose of the Study:
- To investigate the therapeutic potential of OECs derived from the nasal olfactory mucosa for spinal cord repair.
- To evaluate functional recovery after transplantation of nasal OECs in a rat model of complete spinal cord transaction.
- To establish methods for culturing human nasal OECs for clinical application.
Main Methods:
- Harvesting olfactory ensheathing cells from the nasal olfactory mucosa.
- Transplantation of nasal OECs into rats with surgically induced complete spinal cord transaction.
- Assessment of functional recovery, including motor behaviors and breathing, post-transplantation.
- Development of protocols for growing human nasal OECs from biopsy samples.
Main Results:
- Nasal olfactory ensheathing cell transplantation led to significant functional improvement in rats with complete spinal cord transaction.
- Evidence of axon regrowth across the injury site was observed.
- Transplanted OECs facilitated recovery of behaviors such as climbing, walking, reaching, and breathing.
Conclusions:
- Nasal olfactory ensheathing cells are a viable and accessible source for promoting spinal cord regeneration and functional recovery.
- These findings support the clinical translation of nasal OEC transplantation for human spinal cord injuries.
- A Phase I clinical trial using human nasal OECs for paraplegic patients has been initiated.